Table 2.
Cardiovascular (CV) disease risk factors and medications at time of stress test for those with and without CV events during follow-up
| Variable | CV Events (n=96) | No CV Events (n=984) | P-Value |
|---|---|---|---|
| CV disease risk factors | 3.0±1.2 | 2.7±1.5 | 0.02 |
| No risk factors for CV disease | 5 (5.2%) | 58 (5.9%) | >0.99 |
| Family history of CV disease | 24 (25.0%) | 288 (29.3%) | 0.57 |
| Diabetes Mellitus | 26 (27.1%) | 171 (17.4%) | 0.07 |
| Smoker | 19 (19.8%) | 220 (22.4%) | 0.71 |
| Hypertension | 68 (70.8%) | 456 (46.3%) | 0.01 |
| Dyslipidemia | 74 (77.1%) | 473 (48.1%) | <0.01 |
| Obesity | 33 (34.4%) | 379 (38.5%) | 0.68 |
| Prior coronary artery disease | 48 (50.0%) | 150 (15.2%) | <0.01 |
| Medications per patient | 3.2±1.7 | 1.7±1.7 | <0.01 |
| No medications | 9 (9.4%) | 353 (35.9%) | <0.01 |
| β blockers | 54 (56.3%) | 211 (21.4%) | <0.01 |
| Ca2+ blockers | 22 (22.9%) | 124 (12.6%) | 0.02 |
| ACE inhibitors | 33 (34.4%) | 202 (20.5%) | 0.02 |
| Angiotensin receptor blockers | 22 (22.9%) | 183 (18.6%) | 0.43 |
| Nitrates | 13 (13.5%) | 20 (2.0%) | <0.01 |
| Statins | 58 (60.4%) | 413 (42.0%) | 0.04 |
| Diuretics | 11 (11.5%) | 67 (6.8%) | 0.15 |
| Aspirin | 53 (55.2%) | 331 (33.6%) | <0.01 |
| P2y12 inhibitor | 25 (26.0%) | 85 (8.6%) | <0.01 |
Values show number of cases (n), ± SD or percentage (%) of the group. ACE; Angiotensin-converting enzyme.